Terminal · Institutions
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
MWG Caph Ltd (CIK 2111120) reported $72.4M across 3 reported positions in its SEC 13F filing for 2025-12-31. Largest positions: BEAM ($35.1M, 48.53%), LYEL ($31.0M, 42.88%), PRME ($6.2M, 8.59%). Source: SEC Form 13F.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | BEAM | BEAM THERAPEUTICS INC | $35.1M | 48.53% | 1.3M | New |
| 2 | LYEL | LYELL IMMUNOPHARMA INC | $31.0M | 42.88% | 1.0M | New |
| 3 | PRME | PRIME MEDICINE INC | $6.2M | 8.59% | 1.8M | New |
Source: SEC Form 13F filings · as of 2025-12-31